Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in 10X GENOMICS INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 169,589 shares of TXG (10X GENOMICS INC), worth $2.8M as of 2025-Q4. The position was increased (++14.3% shares). TXG represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$2.8M
Current Shares
169,589
Total Value Change
-$34.7M
Total Shares Change
-1.8M
Other major holders of TXG: CAPITAL FUND MANAGEMENT S.A., DnB Asset Management AS, BANQUE PICTET & CIE SA, BAILLIE GIFFORD & CO
Increased |
| 169,589 |
+14.3% |
| $2.8M |
| 0.0% |
| $16.29 |
30 |
| 2025-Q3 | Decreased | 148,387 | -43.5% | $1.7M | 0.0% | $11.34 | 0 |
| 2025-Q2 | Decreased | 262,648 | -96.3% | $3M | 0.0% | $11.73 | 0 |
| 2025-Q1 | Increased | 7.1M | +235.6% | $62M | 0.0% | $9.16 | 48 |
| 2024-Q4 | Increased | 2.1M | +10.1% | $30.4M | 0.0% | $14.35 | 32 |
| 2024-Q3 | Decreased | 1.9M | -0.2% | $43.4M | 0.0% | $22.67 | 0 |
| 2024-Q2 | Increased | 1.9M | +1330.4% | $37.5M | 0.0% | $19.45 | 47 |